Skip to Main Content

Author Details

Bego??a Campos
The University of Cincinnati
1994
67
21
PMIDPaper TitleJournal TitlePublished Year
34553619A pig model of tunneled dialysis catheter (TDC) infection and dysfunction: Opportunities for therapeutic innovation.J Vasc Access2023
37557022Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes.Lung Cancer2023
36988401Adjuvant dabrafenib and trametinib for patients with resected BRAF -mutated melanoma: DESCRIBE-AD real-world retrospective observational study.Melanoma Res2023
36983628Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection Fraction.J Pers Med2023
35935026The Role of Complement Split-products as Biomarkers for Acute Antibody-mediated Rejection of Kidney Allografts.Transplant Direct2022
35538861Venous Thromboembolism In Cancer Patients: "From Evidence to Care".Clin Appl Thromb Hemost2022
36335799Real-world data with afatinib in Spanish patients with treatment-naïve non-small-cell lung cancer harboring exon 19 deletions in epidermal growth factor receptor (Del19 EGFR): Clinical experience of the Galician Lung Cancer Group.Cancer Treat Res Commun2022
34853302Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial.Nat Commun2021
30314840ACE2 and ACE in acute and chronic rejection after human heart transplantation.Int J Cardiol2019
29301761Uremic Advanced Glycation End Products and Protein-Bound Solutes Induce Endothelial Dysfunction Through Suppression of Krüppel-Like Factor 2.J Am Heart Assoc2018
28606659M2 Monocyte Microparticles Are Increased in Intracerebral Hemorrhage.J Stroke Cerebrovasc Dis2017
27718443Use of serum levels of high sensitivity troponin T, galectin-3 and C-terminal propeptide of type I procollagen at long term follow-up in heart failure patients with reduced ejection fraction: Comparison with soluble AXL and BNP.Int J Cardiol2016
27872884Data on clinical characteristics of a heart failure patients' cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers; high sensitivity troponin T, galectin-3, C-terminal propeptide of type I procollagen, soluble AXL and BNP.Data Brief2016
25874698Frequency and characteristics of familial melanoma in Spain: the FAM-GEM-1 Study.PLoS One2015
24261988New techniques for determining the longitudinal effects of local hemodynamics on the intima-media thickness in arteriovenous fistulae in an animal model.Semin Dial2014
24865128Proliferation patterns in a pig model of AV fistula stenosis: can we translate biology into novel therapies?Semin Dial2014
24681018AXL receptor tyrosine kinase is increased in patients with heart failure.Int J Cardiol2014
24341903Comparative analysis of cellular phenotypes within the neointima from vein segments collected prior to vascular access surgery and stenotic arteriovenous dialysis accesses.Semin Dial2014
24500849Natural history of venous morphologic changes in dialysis access stenosis.J Vasc Access2014
24043320Pathogenetic role for early focal macrophage infiltration in a pig model of arteriovenous fistula (AVF) stenosis.J Vasc Access2014
24217332Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel.Anticancer Drugs2014
23078139Influence of renal replacement therapy on immune response after one and two doses of the A(H1N1) pdm09 vaccine.Influenza Other Respir Viruses2013
24071536Biweekly XELOX (capecitabine and oxaliplatin) as first-line treatment in elderly patients with metastatic colorectal cancer.J Geriatr Oncol2013
24011582Arteriovenous fistula failure: is there a role for epigenetic regulation?Semin Nephrol2013
23036686Analysis of the arrhythmogenic substrate in human heart failure.Cardiovasc Pathol2013
22452638Preexisting venous calcification prior to dialysis vascular access surgery.Semin Dial2012
23217336Balloon-assisted maturation (BAM) of the arteriovenous fistula: the good, the bad, and the ugly.Semin Nephrol2012
23151987Of veins, valves, and vascular access!Kidney Int2012
22908978Back to the future: how biology and technology could change the role of PTFE grafts in vascular access management.Semin Dial2012
19741461Mammalian target of rapamycin inhibition prevents glomerular hypertrophy in a model of renal mass reduction.Transplantation2009
17889142Effect of apolipoprotein E polymorphism on renal transplantation.Transplant Proc2007
17918145Thrombospondin-1 mRNA expression in experimental kidney transplantation with heart-beating and non-heart-beating donors.J Nephrol2007
17606807Endothelial microparticle levels are similar in acute ischemic stroke and stroke mimics due to activation and not apoptosis/necrosis.Acad Emerg Med2007
15993942Expression of NADPH oxidase isoform 1 (Nox1) in human placenta: involvement in preeclampsia.Placenta2006
17003084Induction of surfactant protein A expression by cortisol facilitates prostaglandin synthesis in human chorionic trophoblasts.J Clin Endocrinol Metab2006
16954170Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction.Nephrol Dial Transplant2006
16338467Determination of non-bilayer phospholipid arrangements and their antibodies in placentae and sera of patients with hypertensive disorders of pregnancy.Placenta2006
16280369Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular haemodynamics and proteinuria.Nephrol Dial Transplant2006
16386540Effect of calcineurin inhibitors on low-density lipoprotein oxidation.Transplant Proc2005
17523775Docetaxel as single-agent treatment in elderly patients with advanced breast cancer.Clin Drug Investig2005
16386541Effect of apolipoprotein B polymorphism in kidney transplantation.Transplant Proc2005
14768063Antibodies to non-bilayer phospholipid arrangements induce a murine autoimmune disease resembling human lupus.Eur J Immunol2004
15593053Association of TGF-beta1 polymorphisms with chronic renal disease.J Nephrol2004
15355961Annexin 6 modulates the maxi-chloride channel of the apical membrane of syncytiotrophoblast isolated from human placenta.J Biol Chem2004
12401794Interfacial basic cluster in annexin V couples phospholipid binding and trimer formation on membrane surfaces.J Biol Chem2003
14499348CyclinB1 expression is elevated and mitosis is delayed in HeLa cells expressing autonomous CaMKII.Cell Signal2003
12962772Effect of apolipoprotein polymorphisms in renal transplant recipients.Transplant Proc2003
14602805Glucocorticoids induce cytosolic phospholipase A2 and prostaglandin H synthase type 2 but not microsomal prostaglandin E synthase (PGES) and cytosolic PGES expression in cultured primary human amnion cells.J Clin Endocrinol Metab2003
14558330[Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients].Nefrologia2003
12777850Expression of transforming growth factor-beta1 and hypoxia-inducible factor-1alpha in an experimental model of kidney transplantation.Transplantation2003
  • 1 - 50 of 67

Recommended Authors

Fei Fang
University of Pittsburgh
Career Start Year 2006
Number of shared co-authors 0
Jamie R Privratsky
Durham VA and Duke University Medical Center
Career Start Year 2003
Number of shared co-authors 0
Ana Velic
Interfaculty Institute for Cell Biology.
Career Start Year 2003
Number of shared co-authors 0
Samir M Parikh
The Ohio State University Wexner Medical Center
Career Start Year 2002
Number of shared co-authors 0
Mark S Segal
University of Florida
Career Start Year 2001
Number of shared co-authors 0
Gregory A Gibson
University of Pittsburgh
Career Start Year 1999
Number of shared co-authors 0
Carmen Avila-Casado
University Health Network
Career Start Year 1998
Number of shared co-authors 0
Vincenzo Cantaluppi
University of Eastern Piedmont.
Career Start Year 1998
Number of shared co-authors 0
Pampee P Young
Vanderbilt University Medical Center
Career Start Year 1996
Number of shared co-authors 0
Rohan John
University of Toronto
Career Start Year 1996
Number of shared co-authors 0
Mukut Sharma
Midwest Veterans' Biomedical Research Foundation, KCVA Medical Center
Career Start Year 1996
Number of shared co-authors 0
Jeannig Berrou
Universite Paris Cite, Institut de Recherche Saint-Louis
Career Start Year 1995
Number of shared co-authors 0
Jacob Odeberg
The Arctic University of Norway
Career Start Year 1995
Number of shared co-authors 0
Isabelle Cloutier
Faculte de pharmacie, Universite Laval
Career Start Year 1994
Number of shared co-authors 0
Markus Bitzer
University of Michigan ann arbor
Career Start Year 1994
Number of shared co-authors 0
Isaac E Stillman
Mount Sinai Hospital
Career Start Year 1992
Number of shared co-authors 0
Jennifer L Hall
Institute for Precision Cardiovascular Medicine
Career Start Year 1992
Number of shared co-authors 0
Marie-Jos??e H??bert
Universite de Montreal
Career Start Year 1991
Number of shared co-authors 0
Susan E Crawford
NorthShore University HealthSystem, Research Institute, 1001 University Place
Career Start Year 1990
Number of shared co-authors 0
Fabia Gamboni
University of Colorado Anschutz Medical Campus
Career Start Year 1986
Number of shared co-authors 0
Jeffrey B Kopp
National Institutes of Health, National Institute of Diabetes
Career Start Year 1983
Number of shared co-authors 0
Daniel Cruz
University of California Los Angeles
Career Start Year 1982
Number of shared co-authors 0
Kenneth Walsh
University of Virginia School of Medicine
Career Start Year 1982
Number of shared co-authors 0
Simon C Watkins
Center for Molecular Imaging, University of Pittsburgh School of Medicine
Career Start Year 1981
Number of shared co-authors 0
John R Bradley
Cambridge University Hospitals NHS Foundation
Career Start Year 1979
Number of shared co-authors 0
Ludwig Wagner
Child and Family Research Institute, University of British Columbia
Career Start Year 1979
Number of shared co-authors 0
Joseph V Bonventre
Brigham & Women's Hospital
Career Start Year 1975
Number of shared co-authors 0
Vincent Ricchiuti
Laboratory Corporation of America Holdings (LabCorp)
Career Start Year 1974
Number of shared co-authors 0
Victor J Dzau
National Academy of Medicine.
Career Start Year 1974
Number of shared co-authors 0
Hartmut Schl??ter
University Medical Center Hamburg-Eppendorf
Career Start Year 1969
Number of shared co-authors 0

Collaborators

Kimberly W Hart
Vanderbilt University Medical Center
Co-authored papers 1
Christopher J Lindsell
Duke University
Co-authored papers 1
Kyle B Walsh
University of Cincinnati
Co-authored papers 1
Richard A Walsh
Co-authored papers 1
William J Howat
Cancer Research UK Cambridge Institute
Co-authored papers 1
Vincenzo L Pascali
Co-authored papers 1
Justin B Williams
Brooke Army Medical Center
Co-authored papers 1
Edward C Jauch
University of North Carolina Health Sciences at Mountain Area Health Education Center
Co-authored papers 1
Opeolu Adeoye
Washington University School of Medicine
Co-authored papers 1
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Co-authored papers 1
Robert J Linhardt
Rensselaer Polytechnic Institute
Co-authored papers 1
Rose P Webster
Co-authored papers 1
Panjamaporn Sangwung
Co-authored papers 1
Lynne E Wagoner
The Heart Institute, Mercy Hospital
Co-authored papers 1
Release 1.2